Peripherally Inserted Central Catheters Market Synopsis:<\/p>\n
Peripherally Inserted Central Catheters Market Size Was Valued at USD 979.03 Million in 2023, and is Projected to Reach USD 1,769 Million by 2032, Growing at a CAGR of 6.8 % From 2024-2032.<\/p>\n
The peripherally inserted central catheters (PICC) market encompasses centrally inserted long-term vascular access devices used for administering medicines, nutrients or fluids in the patient\u2019s peripheral veins. PICCs are long, thin, flexible tubes inserted through one of the peripheral veins of the commonly exercised areas of the arm then threaded to a large central vein, near the heart. They are very useful in the cases when patient requires long-term administration of IN infusion for such procedures as chemotherapy, antibiotic therapy, TPN (Total Parenteral Nutrition). The development of PICC has therefore been influenced by rising prevalence of chronic diseases requiring long-term IV therapy and advances in catheter design.<\/p>\n
The increased market demand for PICC is attributed to the demand for safer, more efficient IV therapy, particularly for patient with chronic diseases such as cancer, infection and kidney disease. The need for PICCs is rising as it affords secure extended peripheral IV access in giving Chemotherapy, antibiotics and other therapeutic electrolyte solution. However, similar to other kinds of central venous catheters, complications of the Penny Pin site are not very common regardless of the website\u2019s complexity, and PICCs are less complicated to implant than other CVCs, although the process is not surgical. That is why they are seen to be appropriate for use with the health personnel in non-surgical and outpatient facilities. Because of the measures taken by different hospitals and healthcare services to avoid the probability of infection as well as raising patient\u2019s benefits, PICC has receive more appreciation in different areas around the world and thus positively impacting the growth of the market.<\/p>\n
Moreover, enhancements made to the type of material used in the catheter and methods of insertion have enhanced safety comfort and efficiency when using PICCs across patient populations\u2019 technologies such as antimicrobial coatings and power injectable PICCs which are built to withstand forces of pressure injections used during imaging have expanded the possibilities for the use of these devices in the health care system. The increasing need for these latest PICC lines in hospitals, clinics and home care particularly because of their less invasive, not expensive, longer lasting and better intravenous therapeutic applications are credited for initialization of more advanced PICC market.<\/p>\n
Peripherally Inserted Central Catheters Market Trend Analysis<\/p>\n
Rising Demand for Power-Injectable PICCs<\/p>\n
Another trend observed in present and advancing PICC market is the growing demand and shift towards the power injectable PICCs that facilitate the injections at the rate of contrast agents during diagnostic imaging like computerized axial tomography \u2013 CAT scans. PICCs have some outstanding characteristics; PICCs are power injectable, they can accept high pressure Injection and therefore can be used for both diagnostic and interventional procedures. Specifically, as the frequency for diagnostic imaging rise, power-injectable PICCs still make it a provider\u2019s first choice seeing that no other IV has to be placed to do the scans. Because many establishments have waked up to the reality of having power-injectable PICCs, better patients\u2019 experience and rare cases of many patients needing multiple venous access in future.<\/p>\n
Growing Home Healthcare Services<\/p>\n
Home health care services is which might be one of the significant opportunities in the growth of the PICC market. Many patients including those with chronic diseases appreciate home care procedures occasioned by telemedicine more than admissions. Novel research suggest that the large number of clients undergoing home IV therapy for long term need PICCs since this procedure does not impose any side effects on the client. Home healthcare is quickly growing specially because of ageing population, high cost of health care, and mobile health care equipment\u2019s. This trend can be one method by which manufacturers of PICC make them available to home healthcare and bring the convenience to the patients who seek home care now.<\/p>\n
Peripherally Inserted Central Catheters Market Segment Analysis:<\/p>\n
Peripherally Inserted Central Catheters Market is Segmented on the basis of Product Type, End User, and Region. <\/p>\n
By Product Type, Double Lumen segment is expected to dominate the market during the forecast period<\/p>\n
The Double Lumen segment should show the highest growth in terms of the required amount of PICC for the estimated period. Multi-lumen PICCs are distinguished by two lumens with a single catheter and provide sufficient number of incompatible substance infusion facilities for the management of comorbidities in the patient. These are a common characteristic of oncological practices and the critical care unit, and of all the other conditions in which patients require IV treatments such as antibiotics and chemotherapy at the same time. Therefore, due to the characteristics which make them acceptable for single and double lumen structures at the same time, double lumen PICCs can be widely used in hospitals and outpatient clinics, where the efficiency and rapidity of multi-destination medication administration is a critical factor in patients\u2019 condition. Given that patient today are more prone to multiple symptom multiple system ailments the need for double lumen PICCs will persist.<\/p>\n
By End User, Hospitals and Clincs segment expected to held the largest share <\/p>\n
It also expected that the Hospitals and Clinics segment will be the largest market in the PICC Global Market. Therefore, PICCs are adopted in the hospitals and clinic much because patients who require a long time with IV therapy because of chronic diseases, infection, or the needs after surgical operations. Hospital especially uses PICCs due to its safety, easy to identify and cheaper than normal central lines. Clinics are also taken to embracing the use of PICCs since full outpatient treatments are on the rise; the patient does not have to be hospitalized for long. To eradicate chances of getting infection and giving quality care to the patient, healthcare organizations will continue to employ large amount of PICCs use in the hospitals and clinics, thus driving this segment.<\/p>\n
Peripherally Inserted Central Catheters Market Regional Insights: <\/p>\n
North America is Expected to Dominate the Market Over the Forecast period <\/p>\n
North America is anticipated to own the largest share in the PICC market in the future due to well-developed points of healthcare, increasing prevalence of chronic diseases, and a rising interest in minimally invasive IV therapy delivery systems. Among the mentioned regions, the United States is on the top of the list in this regard as it has a sophisticated clinical sector, which is confronting a major challenge of investing in infection control processes, patients\u2019 comfort, as well as effective drug delivery services. Because IV therapy is needed for an extended period with chronic diseases such as cancer, diabetes mellitus, and heart diseases that are prevalent in North America, the demand for PICCs is high. Furthermore, the increased adoption of innovative medical catheters by various politicians and the highest manufacturing companies of such equipment supported by the years of research and development for enhanced technology regarding the catheter boost North America\u2019s market.<\/p>\n
Additionally, the reimbursement policies and guidelines on the use of healthcare products in North America support the use of PICCs owing to increased hospital and outpatient use. Since healthcare providers and patients become more informed with the advantages of using PICCs such as its reduced infection rate and convenience the use of the device is continually increasing. Given the push for decreasing Haem infections and patients\u2019 length of stay in the hospital, PICCs have significantly assumed great importance in I.V therapy in North America. While the technology for catheter is rapidly improving, with more and more people understanding the correct way to have safe intravenous access, the market demand of the PICCs in the region will maintain the dominance of PICC market in the international market.<\/p>\n
Active Key Players in the Peripherally Inserted Central Catheters Market:<\/p>\n
Angio Dynamics, Inc. (United States)<\/p>\n
B. Braun Melsungen AG (Germany)<\/p>\n
Becton, Dickinson and Company (United States)<\/p>\n
Boston Scientific Corporation (United States)<\/p>\n
C.R. Bard, Inc. (United States)<\/p>\n
Cook Medical LLC (United States)<\/p>\n
Fresenius Medical Care AG & Co. KGaA (Germany)<\/p>\n
ICU Medical, Inc. (United States)<\/p>\n
Medtronic plc (Ireland)<\/p>\n
Merit Medical Systems, Inc. (United States)<\/p>\n
Smiths Medical (United Kingdom)<\/p>\n
Teleflex Incorporated (United States)<\/p>\n
Terumo Corporation (Japan)<\/p>\n
Vygon S.A. (France)<\/p>\n
ZOLL Medical Corporation (United States)<\/p>\n
Other Active Players<\/p>\n","protected":false},"excerpt":{"rendered":"
The peripherally inserted central catheters (PICC) market encompasses centrally inserted long-term vascular access devices used for administering medicines, nutrients or fluids in the patient\u2019s peripheral veins. PICCs are long, thin, flexible tubes inserted through one of the peripheral veins of the commonly exercised areas of the arm then threaded to a large central vein, near the heart.<\/p>\n","protected":false},"featured_media":5460,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-9195","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n